Type
1.
Elkanah, Swemwua, Elkanah, Madara, Kela, Samaila, et al. Status of lymphatic filariasis in five communities of Yorro Local Government Area, Taraba State, Nigeria. The Nigerian journal of parasitology. 2018;39(1).
Type
1.
Ikawati B, Wijayanti T, Jastal. The threat of lymphatic filariasis elimination failure in Pasaman Barat District, West Sumatra Province. Indian journal of public health research & development. 2018;9(6):446-51.
Type
1.
Woode ME, Khan J, Thomson R, Niessen LW, COUNTDOWN Consortium. Equity and efficiency in the scaled-up implementation of integrated neglected tropical disease control: the health economics protocol of the COUNTDOWN multicountry observational study in Ghana, Cameroon and Liberia. BMJ open [Internet]. 2018;8(6):e020113. Available from: https://bmjopen.bmj.com/content/bmjopen/8/6/e020113.full.pdf
Type
1.
Kelly-Hope L, Blundell H, Macfarlane C, Molyneux D. Innovative surveillance strategies to support the elimination of filariasis in Africa. Trends in parasitology. 2018;.
Type
1.
Griswold E, Eigege A, Ityonzughul C, Emukah E, Miri E, Anagbogu I, et al. Evaluation of treatment coverage and enhanced mass drug administration for onchocerciasis and lymphatic filariasis in five local government areas treating twice per year in Edo State, Nigeria. The American journal of tropical medicine and hygiene. 2018;.
Type
1.
Abdulmalik J, Nwefoh E, Obindo J, Dakwak S, Ayobola M, Umaru J, et al. Emotional difficulties and experiences of stigma among persons with lymphatic filariasis in Plateau State, Nigeria. Health and human rights journal [Internet]. 2018;20(1):27-40. Available from: https://cdn2.sph.harvard.edu/wp-content/uploads/sites/125/2018/06/Abdulmalik.pdf
Type
1.
Kelly-Hope L, Hemingway J, Taylor M, Molyneux D. Increasing evidence of low lymphatic filariasis prevalence in high risk Loa loa areas in Central and West Africa: a literature review. Parasites & vectors [Internet]. 2018;11(1):349. Available from: https://parasitesandvectors.biomedcentral.com/track/pdf/10.1186/s13071-018-2900-y
Type
1.
Titaley C, Damayanti R, Soeharno N, Mu’asyaroh A, Bradley M, Lynam T, et al. Assessing knowledge about lymphatic filariasis and the implementation of mass drug administration amongst drug deliverers in three districts/cities of Indonesia. Parasites & vectors [Internet]. 2018;11:14. Available from: https://tinyurl.com/y9ct9b6n
Type
1.
Dorkenoo MA, Bronzan R, Yehadji D, Tchalim M, Yakpa K, Etassoli S, et al. Surveillance for lymphatic filariasis after stopping mass drug administration in endemic districts of Togo, 2010-2015. Parasites & vectors [Internet]. 2018;11(1):244. Available from: https://parasitesandvectors.biomedcentral.com/track/pdf/10.1186/s13071-018-2843-3
Type
1.
Sharma, GM, Bhardwaj A, DNB, Relwani, NR, Med MC, Dubey, S, et al. Lymphatic filariasis presenting as a swelling over the upper arm: A case report. Malaysian orthopaedic journal [Internet]. 2018;12(1):63-5. Available from: http://morthoj.org/2018/v12n1/lymphatic-filariasis.pdf